Request Info

Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

News Releases

News Release Search
2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998
11/16/2000Meridian Diagnostics, Inc. Announces Fiscal Year 2000 Operating Results
CINCINNATI--(BW HealthWire)--Nov. 16, 2000--Meridian Diagnostics, Inc. (Nasdaq:KITS) Meridian Diagnostics, Inc. Reports fiscal year 2000 per share earnings of $0.49 vs. $0.14 Undertakes European restructuring Announces planned name and NASDAQ symbol change to reflect expanding business capabilities Declares regular cash dividend and increases indicated rate for fiscal 2001 O... 
 Printer Friendly Version
11/14/2000Meridian Diagnostics, Inc. Invites You to Participate in its Conference Call to discuss Fiscal Year 2000 Earnings on Thursday, November 16, 2000 at 3:00 p.m. ET
CINCINNATI--(BW HealthWire)--Nov. 14, 2000--Meridian Diagnostics, Inc. (Nasdaq:KITS) expects to release Fiscal Year 2000 earnings on Thursday, November 16, 2000. There are two alternative communication modes available for you to listen to the call. Option No. 1 ------------ Over the Telephone Call 1-800-491-3423 (domestic) or 303-267-1007 (international), Conference ID 859812. If you plan to participate in the conference call via the telephone, please RSVP to Meridi... 
 Printer Friendly Version
11/1/2000Meridian Diagnostics, Inc. Appoints New Director to its Board
CINCINNATI--(BW HealthWire)--Nov. 1, 2000--Meridian Diagnostics, Inc., (Nasdaq:KITS) today announced that it has appointed David C. Phillips to the Company's Board of Directors, effective immediately. The appointment of Mr. Phillips fills a vacant seat on the Board that has been open since July 1999. Mr. Phillips was with the international accounting firm of Arthur Andersen for 32 years and served in a variety of positions prior to his retirement as firm-wide Managing Part... 
 Printer Friendly Version
10/18/2000Meridian Diagnostics Recognized as One of Forbes 200 Best Small Companies
CINCINNATI--(BW HealthWire)--Oct. 18, 2000--Meridian Diagnostics, Inc., Cincinnati, Ohio (Nasdaq:KITS) today announced that it has been recognized as one of the "Forbes 200 Best Small Companies" as reported in the October 17, 2000 issue of Forbes magazine. The Forbes 200 Best Small Companies list is selected following a comprehensive evaluation of financial results plus additional operating factors of candidate companies having sales between $5 million and $350 million. A... 
 Printer Friendly Version
9/27/2000Meridian Diagnostics Expands Research Partnership with Texas Tech University and Completes Acquisition of Viral Antigens
CINCINNATI, Sept. 27 /PRNewswire/ -- Meridian Diagnostics, Inc. (Nasdaq: KITS) today announced that it has entered into an expanded research agreement with Texas Tech University Health Sciences Center (Lubbock, TX) and Dr. K. John Morrow, Jr. for the development of highly specific, gene-mediated antigen and antibody systems. This project is expected to yield more specific and sensitive biologicals for use in diagnosing and treating disease. Morrow and his Texas Tech collaborato... 
 Printer Friendly Version
9/14/2000Meridian Signs Agreement to Acquire Viral Antigens, Inc.
CINCINNATI--(BW HealthWire)--Sept. 14, 2000--Meridian Diagnostics, Inc. (Nasdaq:KITS) Leading producer of highly specialized biologicals Expands Meridian's biotechnology capabilities Technology rich, strong proprietary know-how Highly profitable, sound balance sheet Accretive earnings expected Meridian Diagnostics, Inc., Cincinnati, Ohio, (Nasdaq:KITS) today announced it has executed de... 
 Printer Friendly Version
8/30/2000Meridian Signs Major Agreement for Advanced Technology Development
CINCINNATI--(BW HealthWire)--Aug. 30, 2000--Meridian Diagnostics, Inc. (NASDAQ:KITS) today announced that it has entered into exclusive long-term Research, Development and Supply Agreements with STC Technologies, Inc. Bethlehem, PA for a highly sensitive proprietary multi-test diagnostic system. The scope of these agreements includes the development, manufacturing, and sale of a broad range of rapid tests for the detection of infectious diseases including, but not limited to, parasi... 
 Printer Friendly Version
8/28/2000Meridian Announces Major Expansion of Its Biotechnology Resources
CINCINNATI--(BW HealthWire)--Aug. 28, 2000-- Leveraging of Meridian's antibody capabilities Collaboration with university, biotech, and pharmaceutical partners Use of genomic and proteomic science Novel drug and vaccine discovery support, and related diagnostic assays Meridian Diagnostics, Inc., (NASDAQ: KITS) today announced an expansion of its capabilities in biotechnology, research reagent developme... 
 Printer Friendly Version
7/21/2000Meridian Diagnostics Announces Record Third Quarter and Nine Months Operating Results and Declares Regular Cash Dividend
CINCINNATI--(BW HealthWire)--July 21, 2000--Meridian Diagnostics, Inc. (Nasdaq:KITS) After restating 1999 for a nonmaterial bookkeeping error: Third quarter sales, excluding the impact of currency, increased 9% Third quarter net earnings increased 72% Third quarter EBITDA increased 40% Net income for the first 9 months increased 79% EBITDA for the first 9 months increased 41% Gull Salt Lake City facility sold Meridi... 
 Printer Friendly Version
4/20/2000Meridian Diagnostics Announces Record Earnings
Second quarter net earnings increased 47% Second quarter EBITDA increased 28% Net income for the first 6 months increased 84% EBITDA for the first 6 months increased 44% CINCINNATI--(BW HealthWire)--April 20, 2000--Meridian Diagnostics, Inc. (Nasdaq:KITS) Meridian Diagnostics, Inc. (Nasdaq:KITS) today announced that net earnings for the second quarter of this fiscal year were a record $1,849,000, or $0.13 per share, compared to $1,256,... 
 Printer Friendly Version
4/6/2000New Study Reports Genital Herpes Can Be Spread By Asymptomatic Individuals
CINCINNATI--(BW HealthWire)--April 6, 2000--Meridian Diagnostics, Inc., Cincinnati, Ohio, (Nasdaq:KITS) today announced a recently published study has determined that individuals infected with genital herpes, usually HSV Type 2, can spread the virus to others even when symptoms are not present. This research, published in the New England Journal of Medicine and conducted by Dr. Anna Wald, medical director of the University of Washington's Virology Research Clinic, indicated that infected ... 
 Printer Friendly Version
3/21/2000Meridian Diagnostics Acquires Technology & Marketing Rights From La Jolla Diagnostics for Rapid Tuberculosis -- TB -- Test
CINCINNATI--(BW HealthWire)--March 21, 2000--Meridian Diagnostics, Inc., Cincinnati, Ohio, (Nasdaq:KITS) and La Jolla Diagnostics (LAJD) today announced an agreement for an undisclosed cash payment and future royalties for a unique rapid blood test for active tuberculosis from the DiagnosTech subsidiary of La Jolla Diagnostics, Inc. The test utilizes a combination of three highly specialized Mycobacterium tuberculosis antigens that will react with blood serum from persons having active TB... 
 Printer Friendly Version
2/22/2000Meridian Receives FDA Clearance To Market Premier C. difficile Toxins A&B
CINCINNATI--(BW HealthWire)--Feb. 22, 2000--Meridian Diagnostics, Inc., (Nasdaq:KITS) today announced that it has received clearance from the United States Food and Drug Administration (FDA) to market Premier™ C. difficile Toxins A&B, the sixth member of the company's C. difficile product family. Toxigenic C. difficile is the major cause of Antibiotic Associated Diarrhea (AAD) and Antibiotic Associated Pseudo-membranous Colitis (PMC), two serious conditions that can ... 
 Printer Friendly Version
1/21/2000Meridian's Board of Directors Declares Dividend for First Quarter Operating Results
CINCINNATI--(BW HealthWire)--Jan. 21, 2000--Meridian Diagnostics, Inc. (Nasdaq:KITS) today announced that the Board of Directors declared a dividend of $0.06 per share to be paid February 8, 2000 to shareholders of record as of February 1, 2000. The regular quarterly cash dividend is at an indicated annual rate of $0.24 per share, an increase of 20% over the prior year's annual rates. Yesterday, Meridian announced record first quarter operating results with net sales increasi... 
 Printer Friendly Version
1/20/2000Meridian Announces Record First Quarter Operating Results
CINCINNATI--(BW HealthWire)--Jan. 20, 2000--Meridian Diagnostics, Inc. (Nasdaq:KITS) Net sales increased 22% Net earnings increased 165% EBITDA increased 44% Record fiscal year expected Meridian Diagnostics, Inc. (Nasdaq:KITS) today announced net sales for the first fiscal quarter, which ended December 31, 1999, of $14,329,000 compared to $11,720,000 for the same period of the prior fiscal year. Net earnings for the firs... 
 Printer Friendly Version